But the genome - wide spectrum of mutations associated with
aristolochic acid exposure remained largely unknown.
«Genome - wide sequencing has allowed us to tie
aristolochic acid exposure directly to an individual getting cancer,» Kenneth Kinzler, Ph.D., professor of oncology in the Johns Hopkins Kimmel Cancer Center's Ludwig Center for Cancer Genetics and Therapeutics.
Not exact matches
«I was dumbstruck to find the evidence of
exposure to
aristolochic acid in 78 per cent of cases,» says Rozen.